SC 13G/A | 2019-02-14 | Woodford Patient Capital Trust Plc | Prothena Corp plc | 2,484,408 | 6.2% | EDGAR |
SC 13G/A | 2019-02-14 | LF Woodford Equity Income Fund | Prothena Corp plc | 7,948,790 | 19.9% | EDGAR |
SC 13G/A | 2019-02-14 | Woodford Investment Management Ltd | Prothena Corp plc | 11,924,614 | 29.9% | EDGAR |
SC 13G/A | 2019-02-13 | FMR LLC | Prothena Corp plc | 4,910,430 | 12.3% | EDGAR |
SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Prothena Corp plc | 2,138,787 | 5.4% | EDGAR |
SC 13G/A | 2019-02-06 | BlackRock Inc. | Prothena Corp plc | 3,354,654 | 8.4% | EDGAR |
SC 13G/A | 2019-01-31 | VANGUARD SPECIALIZED FUNDS | Prothena Corp plc | 920,628 | 2.3% | EDGAR |
SC 13G | 2019-01-10 | SCOPIA CAPITAL MANAGEMENT LP | Prothena Corp plc | 4,618,164 | 11.6% | EDGAR |
SC 13G/A | 2018-05-10 | PRICE T ROWE ASSOCIATES INC /MD/ | Prothena Corp plc | 1,516,638 | 3.8% | EDGAR |
SC 13G/A | 2018-02-13 | FMR LLC | Prothena Corp plc | 5,767,014 | 15.0% | EDGAR |
SC 13G/A | 2018-02-13 | CF Woodford Equity Income Fund | Prothena Corp plc | 7,684,790 | 20.0% | EDGAR |
SC 13G/A | 2018-02-13 | Woodford Patient Capital Trust | Prothena Corp plc | 2,550,408 | 6.6% | EDGAR |
SC 13G/A | 2018-02-13 | Woodford Investment Management Ltd | Prothena Corp plc | 11,528,614 | 30.0% | EDGAR |
SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Prothena Corp plc | 3,221,394 | 8.4% | EDGAR |
SC 13G/A | 2018-02-02 | VANGUARD SPECIALIZED FUNDS | Prothena Corp plc | 2,150,294 | 5.6% | EDGAR |
SC 13G/A | 2018-01-30 | BlackRock Inc. | Prothena Corp plc | 2,968,672 | 7.7% | EDGAR |
SC 13G/A | 2018-01-10 | PRICE T ROWE ASSOCIATES INC /MD/ | Prothena Corp plc | 6,103,759 | 15.8% | EDGAR |
SC 13G/A | 2017-02-14 | FMR LLC | Prothena Corp plc | 5,173,264 | 15.0% | EDGAR |
SC 13G/A | 2017-02-14 | CF Woodford Equity Income Fund | Prothena Corp plc | 6,869,266 | 19.9% | EDGAR |
SC 13G/A | 2017-02-14 | Woodford Investment Management Ltd | Prothena Corp plc | 10,310,511 | 29.9% | EDGAR |